Latest Breaking News On - க்ளேண்மர்க் - Page 1 : comparemela.com

Glenmark s consolidated revenues grow 2.8% to Rs 1,09,439 M in FY21 Glenmark s consolidated revenues grow 2.8% to Rs 1,09,439 M in FY21 31 May 2021 | News Registers consolidated net profit of Rs 9,701 M with growth of 25 per cent in FY21 Image credit: Shutterstock.com   Glenmark Pharmaceuticals announced its financial results for the fourth quarter and year ended March 31, 2021. For the fourth quarter of FY 2020-21, Glenmark s consolidated revenue was at Rs 28,599 million as against Rs 27,675 million recording an increase of 3.3 per cent. Consolidated EBITDA grew by 12.4 per cent to Rs 5,234 million in the quarter ended March 31, 2021 as against Rs 4,657 million in the previous corresponding quarter. The consolidated net profit was at Rs 2,339 million for the quarter ended March 31, 2021 as compared to Rs 2,203 million in the previous corresponding quarter, registering an increase of 6.2 per cent.

Glenn saldanhaGlenmark pharmaceuticalsPer shareGlenn saldanhaக்ளென் சால்தான்க்ளேண்மர்க் மருந்துகள்ஒன்றுக்கு பகிர்